Eclampsia Clinical Trial
— PRESIDEXOfficial title:
Eclampsia and Posterior Reversible Encephalopathy Syndrome (PRES): A Randomized Clinical Trial Evaluating Corticosteroid Efficacy to Augment Standard Therapy and Shorten Recovery.
This is a double blinded, placebo-controlled trial to determine if IV dexamethasone more quickly than placebo assists resolution of Posterior Reversible Encephalopathy Syndrome (PRES) encountered in eclamptic patients. All patients regardless of assignment to placebo or steroid will receive standard therapy to include magnesium sulfate, blood pressure medications and diuretics. We hypothesize that the addition of dexamethasone to standard therapy will accelerate CNS recovery more quickly than standard management without dexamethasone.
Status | Terminated |
Enrollment | 1 |
Est. completion date | December 2013 |
Est. primary completion date | December 2013 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion Criteria: 1. Currently 34 weeks pregnant or within 6 weeks postpartum 2. At least 18 years of age 3. Singleton or twin gestation 4. Patient or family sign informed consent 5. Diagnosis of eclampsia 6. Able to obtain MRI scanning within 24hours of hosp admit and/or seizure Exclusion Criteria: 1. Neither pregnant nor within first 6 weeks postpartum 2. Patient or family unable to sign informed consent 3. Less than 18 years of age 4. Triplet or higher order gestation 5. Unable to obtain MRI scanning within 24 hours of hospital admission ( 6. Diagnosis of cerebral hemorrhage 7. Patient in whom MRI is contraindicated |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | University of Mississippi Medical Center | Jackson | Mississippi |
Lead Sponsor | Collaborator |
---|---|
University of Mississippi Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Eclampsia and Posterior Reversible Encephalopathy Syndrome (PRES): Arandomized clinical trial evaluating corticosteroid efficacy to augment standard therapy and shorten recovery | To learn if giving IV dexamethasone to eclamptic women with PRES will accelerate normalization of CNS function. | 36 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02911701 -
Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features
|
Phase 4 | |
Recruiting |
NCT06377878 -
The Preeclampsia Registry
|
||
Recruiting |
NCT02020174 -
The Preeclampsia Registry
|
||
Completed |
NCT05121415 -
Investigation of Genetic Disease Marker Associated With Spontaneous Haemorrhagic Stroke Complicating Severe Pre-eclampsia in Pregnancy
|
||
Recruiting |
NCT02578810 -
PIERS and BIS, sFIT:PIGF, Adrenomedullin
|
||
Recruiting |
NCT02920593 -
A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy
|
Phase 4 | |
Completed |
NCT05143710 -
The Clinical and Prognostic Features of PRES
|
||
Completed |
NCT03028194 -
Postpartum Uterine Curettage in the Recovery From Preeclampsia/Eclampsia
|
N/A | |
Recruiting |
NCT05678062 -
Point-of-care Ultrasound Abnormalities in Eclampsia
|
N/A | |
Unknown status |
NCT02256995 -
uChek Pilot Study for Urinalysis in the Antenatal Care Setting
|
N/A | |
Completed |
NCT01751945 -
Improved Accessibility of EmONC Services for Maternal and Newborn Health: a Community Based Project
|
N/A | |
Recruiting |
NCT06069102 -
Optimal Blood Pressure Treatment Thresholds Postpartum
|
Phase 4 | |
Recruiting |
NCT06219109 -
Pulmonary Edema Resolution in Severe Preeclampsia and Eclampsia
|
||
Recruiting |
NCT06281665 -
Treatment With Aspirin After Preeclampsia: TAP Trial
|
Phase 4 | |
Completed |
NCT02765906 -
Comparing Different Methods of Patient Education on Preeclampsia
|
N/A | |
Completed |
NCT04160923 -
Incidence and Neonatal Outcome of Eclamptic Parturient in Tertiary Hospital.
|
||
Recruiting |
NCT01856387 -
The Effect of neutrophil-to Lymphocyte Ratio in Preeclampsia- Eclampsia
|
N/A | |
Recruiting |
NCT03200743 -
Catestatin and Hypertension in Pregnancy
|
N/A | |
Not yet recruiting |
NCT04855513 -
Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial
|
N/A | |
Completed |
NCT00000534 -
Calcium for Pre-Eclampsia Prevention (CPEP)
|
Phase 3 |